WilliamJHeimMD

PubMed

• 48 citations
  A randomized, placebo-controlled phase ii study evaluating the reduction of neutropenia and febrile neutropenia in patients with colorectal cancer receiving pegfilgras...
  J. Randolph Hecht, Madhavan V. Pillai, Russell Gollard, William Heim, Forrest Swan, Ravi Patel, Lyndah Dreiling, May Mo, Imtiaz Malik> ;Clinical Colorectal Cancer. 2010 Apr 1
• 3 citations
  A phase 2 study of a fixed combination of uracil and ftorafur (UFT) and leucovorin given orally in a 3-times-daily regimen to treat patients with recurrent metastatic ...
  Gabriel N Hortobagyi, William Heim, Laura Hutchins, Edgardo Rivera, Bernard Mason, Daniel J Booser, Jeffrey Kirshner> ;Cancer. 2010 Mar 15
• 337 citations
  Cetuximab and First-Line Taxane/Carboplatin Chemotherapy in Advanced Non–Small-Cell Lung Cancer: Results of the Randomized Multicenter Phase III Trial BMS099
  Thomas J. Lynch, Taral Patel, Luke Dreisbach, Michael McCleod, William J. Heim, Robert C. Hermann, Eugene Henry Paschold, Nicholas Iannotti, Shaker R. Dakhil, Steven G...> ;Journal of Clinical Oncology. 2010 Feb 20
• Lung cancer symptoms with cetuximab/taxane/carboplatin in first-line advanced NSCLC: Analysis of the BMS099 trial.
  Patel T, Dreisbach L, McCleod M, Heim WJ, Hermann RC, Woytowitz D, Lu H, Weber MR, Lynch TJ> ;J. Clin. Oncol.. 2009-05-20
• 71 citations
  Combination Chemotherapy and ALVAC-CEA/B7.1 Vaccine in Patients with Metastatic Colorectal Cancer
  Howard L. Kaufman, Heinz-Josef Lenz, John L. Marshall, D. A. Singh, Chris Garett, Christine Cripps, Malcolm J. Moore, Margaret von Mehren, Richard Dalfen, William J. H...> ;Clinical Cancer Research. 2008 Aug 1
• Bevacizumab does not increase bleeding in patients with metastatic colorectal cancer receiving concurrent anticoagulation.
  Hambleton J, Novotny WF, Hurwitz H, Fehrenbacher L, Cartwright T, Hainsworth J, Heim W, Berlin J, Kabbinavar F, Holmgren E> ;J. Clin. Oncol.. 2004-07-15
• Lack of effect of bevacizumab on wound healing/bleeding complications when given 28-60 days following primary cancer surgery.
  Scappaticci F, Fehrenbacher L, Cartwright T, Hainsworth J, Heim W, Berlin J, Kabbinavar F, Novotny W, Hurwitz H> ;J. Clin. Oncol.. 2004-07-15
• Bevacizumab plus irinotecan/5-FU/leucovorin for treatment of metastatic colorectal cancer results in survival benefit in all pre-specified patient subgroups.
  Fyfe GA, Hurwitz H, Fehrenbacher L, Cartwright T, Hainsworth J, Heim W, Berlin J, Kabbinavar F, Holmgren E, Novotny W> ;J. Clin. Oncol.. 2004-07-15
• Wound healing/bleeding in metastatic colorectal cancer patients who undergo surgery during treatment with bevacizumab.
  Hurwitz H, Fehrenbacher L, Cartwright T, Hainsworth J, Heim W, Berlin J, Kabbinavar F, Novotny W, Scappaticci F> ;J. Clin. Oncol.. 2004-07-15
• 15 citations
  A study of infusional cisplatin and infusional fluorouracil for locally advanced or metastatic non-small-cell lung cancer: a Mid-Atlantic Oncology Program study.
  William J. Heim, G L Wampler, Jacob J. Lokich, H D Brereton, S J Scialla, F Laluna, James D. Ahlgren, J Nevin, John G. Fryer, D Alt> ;Journal of Clinical Oncology. 1991 Dec 1
• 22 citations
  Comparison of cyclophosphamide, doxorubicin, and vincristine with an alternating regimen of methotrexate, etoposide, and cisplatin/cyclophosphamide, doxorubicin, and v...
  G L Wampler, William J. Heim, N M Ellison, James D. Ahlgren, John G. Fryer> ;Journal of Clinical Oncology. 1991 Aug 1
• 40 citations
  A prospective randomized comparison of protracted infusional 5-fluorouracil with or without weekly bolus cisplatin in metastatic colorectal carcinoma. A Mid-Atlantic O...
  Jacob J. Lokich, James D. Ahlgren, James Cantrell, William J. Heim, Galen L. Wampler, John J. Gullo, John G. Fryer, Diane E. Alt> ;Cancer. 1991 Jan 1
• Explosive hazard of blood diluents containing sodium azide.
  LaLuna FJ, Wright RE, Heim WJ> ;N. Engl. J. Med.. 1979-08-16
• 18 citations
  Phase II trial of PALA in combination with 5-fluorouracil in advanced pancreatic cancer.
  Rosvold E, Russell J. Schilder, Judy Walczak, DiFino Sm, Flynn Pj, Banerjee Tk, Heim Wj, Paul F. Engstrom, Robert F. Ozols, Peter J. O'Dwyer> ;Cancer Chemotherapy and Pharmacology. 1992 Jan 1
• Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab.
  Scappaticci, F. A., Fehrenbacher, L., Cartwright, T., Hainsworth, J. D., Heim, W., Berlin, J., Kabbinavar, F., Novotny, W., Sarkar, S., Hurwitz, H.> ;J Surg Oncol. 2005 Sep 1
• Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.
  Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., Ferrara, N., Fyfe, G., Rogers,...> ;N Engl J Med. 2004 Jun 3
• Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer.
  Hurwitz, H. I., Fehrenbacher, L., Hainsworth, J. D., Heim, W., Berlin, J., Holmgren, E., Hambleton, J., Novotny, W. F., Kabbinavar, F.> ;J Clin Oncol. 2005 May 20
• Join now to see all